Study Estimates Prevalence of Adolescents Identifying as Being in Recovery
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 1, 2024 -- The prevalence of adolescents identifying as being in recovery and resolving problems with substances is estimated in a study published online Dec. 19 in PLOS ONE.
Douglas C. Smith, Ph.D., from the University of Illinois Urbana-Champaign, and colleagues estimated the prevalence of recovery status in a large statewide epidemiological survey involving high school students in ninth through 12th grades administered between January and March 2020. Youth who reported recovery and problem-resolving dual status (DS), recovery only (RO), and problem resolution only (PRO) were compared to control groups reporting neither status in a propensity score-matched analysis.
The researchers found that the prevalence estimates were 1.4, 2.5, and 2.9 percent for DS, PRO, and RO, respectively. All three groups had significantly lower odds of prescription drug use compared with propensity-matched controls. The odds of past-month cannabis use were lower for the PRO group. No significant differences were seen for alcohol use or binge alcohol use.
"These findings have large implications for medical professionals designing recovery supports for adolescents and emerging adults," Smith said in a statement. "It suggests a pressing need for more research on community-dwelling youth in recovery to uncover the best approaches for engaging them in the course of experiencing a substance use disorder."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-02 06:15
Read more
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- Supply Chain Issues Less Likely to Yield Drug Shortages in Canada Versus U.S.
- Patient-Reported Lumbar Symptom Information Beneficial for Radiologists
- Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- Biden Proposes That Insurers Cover Over-the-Counter Birth Control
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions